Vai al contenuto principale della pagina

FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997 Visualizza cluster
Pubblicazione: Washington : , : U.S. Government Printing Office, , 1998
Descrizione fisica: 1 online resource (iii, 427 pages) : illustrations
Soggetto topico: Plasma products - United States - Safety measures
Blood plasma - Safety measures
Blood - Collection and preservation - United States - Safety measures
Blood - Collection and preservation - Safety measures
Plasma products - Safety measures
Soggetto geografico: United States
Soggetto genere / forma: Legislative hearings.
Note generali: Title from title screen (viewed on Oct. 5, 2015).
"Serial no. 105-70."
Nota di bibliografia: Includes bibliographical references.
Altri titoli varianti: FDA oversight
Titolo autorizzato: FDA oversight  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910708186403321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui